C3 and ovarian carcinoma: Many years ago, Bjørge et al. found elevated levels of complement C1q, C3, C3a, and soluble C5b-9 in ascites from ovarian cancer patients, suggesting that local complement activation may constitute an important soluble component of the ovarian TME [64].